Affluent Medical announces coverage initiation of its stock by Portzamparc – Groupe BNP Paribas.
Affluent Medical announces coverage initiation of its stock by Portzamparc – Groupe BNP Paribas.
- Affluent Medical announces coverage initiation of its stock by Portzamparc – Groupe BNP Paribas.
- Aix-en-Provence, November 27, 2023 – 7:30 am CEST- Affluent Medical (ISIN code: FR0013333077 – ticker: AFME), a French clinical-stage MedTech company specializing in the international development and industrialization of innovative medical prostheses, announces today that Portzamparc - Groupe BNP Paribas has initiated coverage of its stock.
- Portzamparc - BNP Paribas Group began covering the stock with a study entitled "Au plus proche de votre coeur" ("Closer to your heart"), published on November 24, 2023.
- This initiation completes the coverage of Affluent Medical’s stock and adds to the financial analyst consensus alongside Invest Securities and Kepler Cheuvreux.